Literature DB >> 1873746

The effects of the helium-neon laser on postsurgical discomfort: a pilot study.

C Clokie1, K C Bentley, T W Head.   

Abstract

It has been postulated that low-energy lasers (soft lasers) have analgesic capabilities. European investigators who have worked with these lasers have tried to explain this phenomenon as an interference with the mediation of the pain message and/or the stimulation of endorphin production. There does not appear, however, to be much well-controlled research to support these claims. This study has examined the effect of the helium-neon laser on post-surgical discomfort. Fifteen patients who had surgical removal of bilaterally symmetrical mandibular third molars were evaluated. Laser therapy was applied to one side of each patient's mouth with the other side serving as the control. A similar technique of application, without activation of the laser beam, was utilized on the control side. This study has demonstrated that the helium-neon laser (632.8 nanometre (nm) at 10 milliwatt (mW), when applied to the surgical site for three minutes immediately following third molar surgery, reduced postoperative pain on the day of surgery and on the first postoperative day. This finding was statistically significant.

Entities:  

Mesh:

Year:  1991        PMID: 1873746

Source DB:  PubMed          Journal:  J Can Dent Assoc        ISSN: 0709-8936            Impact factor:   1.316


  9 in total

1.  Effect of low-level laser therapy after extraction of impacted lower third molars.

Authors:  Maurizio Ferrante; Morena Petrini; Paolo Trentini; Giorgio Perfetti; Giuseppe Spoto
Journal:  Lasers Med Sci       Date:  2012-07-28       Impact factor: 3.161

2.  The effectiveness of the low-power laser and kinesiotaping in the treatment of carpal tunnel syndrome, a pilot study.

Authors:  A Güner; L Altan; M Kasapoğlu Aksoy
Journal:  Rheumatol Int       Date:  2018-03-28       Impact factor: 2.631

3.  Comparison of the influence of ozone and laser therapies on pain, swelling, and trismus following impacted third-molar surgery.

Authors:  Hakki Oguz Kazancioglu; Seref Ezirganli; Nihat Demirtas
Journal:  Lasers Med Sci       Date:  2013-03-14       Impact factor: 3.161

4.  Placebo-controlled randomized clinical trial of the effect two different low-level laser therapies (LLLT)--intraoral and extraoral--on trismus and facial swelling following surgical extraction of the lower third molar.

Authors:  Mutan Hamdi Aras; Metin Güngörmüş
Journal:  Lasers Med Sci       Date:  2009-05-31       Impact factor: 3.161

5.  Effects of laser irradiation on the release of basic fibroblast growth factor (bFGF), insulin like growth factor-1 (IGF-1), and receptor of IGF-1 (IGFBP3) from gingival fibroblasts.

Authors:  Isil Saygun; Seniz Karacay; Muhittin Serdar; Ali Ugur Ural; Metin Sencimen; Bulent Kurtis
Journal:  Lasers Med Sci       Date:  2007-07-10       Impact factor: 3.161

6.  Laser in dentistry: An innovative tool in modern dental practice.

Authors:  Sanjeev Kumar Verma; Sandhya Maheshwari; Raj Kumar Singh; Prabhat Kumar Chaudhari
Journal:  Natl J Maxillofac Surg       Date:  2012-07

7.  Effects of low level laser therapy on ovalbumin-induced mouse model of allergic rhinitis.

Authors:  Binhye Choi; Mun Seog Chang; Ha Young Kim; Jae-Woo Park; Bongha Ryu; Jinsung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-11       Impact factor: 2.629

8.  Effect of low-level laser therapy on the post-surgical inflammatory process after third molar removal: study protocol for a double-blind randomized controlled trial.

Authors:  Simone Oliveira Sierra; Alessandro Melo Deana; Raquel Agnelli Mesquita Ferrari; Priscilla Maia Albarello; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes
Journal:  Trials       Date:  2013-11-06       Impact factor: 2.279

9.  Evaluation of the effects of the low-level laser therapy on swelling, pain, and trismus after removal of impacted lower third molar.

Authors:  Hilal Alan; Ümit Yolcu; Mahmut Koparal; Cem Özgür; Seyit Ahmet Öztürk; Sıddık Malkoç
Journal:  Head Face Med       Date:  2016-07-26       Impact factor: 2.151

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.